Interstitial Lung Disease

Interstitial Lung Disease Symptoms


Interstitial Lung Disease Symptoms

The symptoms of interstitial lung disease can vary, mainly because it is not a single condition. Rather, it is an umbrella term that is often used to describe more than 200 different pulmonary disorders, all of which cause progressive lung tissue thickening and scarring. The resulting lung damage can make it increasingly difficult to breathe.

With that said, many people who are diagnosed with a form of interstitial lung disease experience one or more of the following symptoms:

  • Shortness of breath
  • Dry, hacking cough
  • Excessive mucus production
  • Bluish skin discoloration due to poor circulation or inadequate blood oxygenation (cyanosis)
  • Pneumonia
  • Joint pain
  • Unexplained weight loss
  • General malaise
  • High blood pressure

Usually, the symptoms are mild at first and worsen over time. For instance, some people initially become breathless while exercising and ultimately find that they have trouble breathing even while at rest. Once lung damage has occurred, it cannot be reversed.

If you are living with the symptoms of interstitial lung disease, you understandably want to find relief. You should know that you may have a treatment option that, unlike medications and supplemental oxygen, can not only help you feel better, but also potentially slow the progression of your lung damage. At the Lung Institute, we offer blood- and bone marrow-based stem cell therapy for chronic lung conditions.

Many patients who choose stem cell therapy as an alternative form of treatment find that their symptoms gradually improve within the days and weeks following a procedure. In addition to breathing easier and becoming less dependent on supplemental oxygen, some patients experience long-term benefits that ultimately improve their quality of life.

The Lung Institute is respected worldwide as a pioneer in regenerative medicine and stem cell research. If you are exploring treatment options for interstitial lung disease, you are encouraged to consider the Lung Institute. For more information on stem cell therapy for chronic lung conditions, contact us at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.